Status:
TERMINATED
Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients
Lead Sponsor:
AGUNCO Obstetrics and Gynecology Centre
Collaborating Sponsors:
Centro Clinico Colle Cesarano Tivoli Rome Italy
Conditions:
Depression
PCOS
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Polycystic ovary syndrome (PCOS) is one of the most common reproductive disorders affecting 5-10% of women of reproductive age. Beside impairments on reproductive functions (oligomenorrhea/amenorrhea)...
Eligibility Criteria
Inclusion
- Women diagnosed of PCOS according to Rotterdam 2003 criteria
Exclusion
- BMI \>30
- Pharmacological treatment in the last 3 moths
- Use of contraceptive pill
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01246310
Start Date
November 1 2010
End Date
February 1 2022
Last Update
March 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Agunco
Rome, Italy, Rome